What makes a blockbuster? Can biotech be taught from Aduhelm? And the way do you exchange a singular regulator?
We cowl all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. We clarify the controversy over Vertex Prescribed drugs’ novel ache drug, whose success in medical trials comes with a large caveat. We additionally speak concerning the newest information within the life sciences, together with an epitaph for Aduhelm and the retirement of an FDA icon.
For extra on what we cowl, right here’s the information on Vertex; right here’s extra on Aduhelm; right here’s the exit interview with Janet Woodcock; right here’s the place you’ll find episodes of Colour Code; right here’s the place you’ll be able to subscribe to the First Opinion Podcast; and right here’s the place you’ll be able to subscribe to our biotech e-newsletter, The Readout.
Remember to enroll on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.
And you probably have any suggestions for us — matters to cowl, friends to ask, vocal tics to stop — you’ll be able to electronic mail [email protected].